SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
tuberculosis
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
993
1
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
2
nosocomial mycobacterium tuberculosis transmission among healthcare students in a high incidence region, in vitória, state of espírito santo transmissão nosocomial por mycobacterium tuberculosis nos estudantes da área de saúde em uma região de alta incidência de tuberculose, vitória, estado do espírito santo
3
comparative characteristics of immunohistochemical detection of m. tuberculosis antigens and mycobacteria by ziehl–neelsen method in lung tissue with tuberculoma during progressive course of tuberculosis
4
importancia e impacto social de la tuberculosis en los niÑos
5
tuberculosis infection in children with proteinuria/nephrotic syndrome
6
investigation of survival rate among hiv-positive individuals identified in isfahan province, 1997-2013 (iran)
7
tuberculosis of the oral cavity misdiagnosed as precancerous lesion
8
gambaran infeksi mycobacterium tuberculosis pada anggota rumah tangga pasien tb paru (studi kasus di wilayah kerja puskesmas darul imarah kabupaten aceh besar)
9
[Primary pulmonary tuberculosis among Tibetan students; 65 cases]
10
[Tuberculosis chemotherapy in cases of resistance]
11
[Experimental use of Sinomin]
12
Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.
13
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.
14
MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
15
The crystal structure of AcrR from Mycobacterium tuberculosis reveals a one-component transcriptional regulation mechanism.
16
Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains
17
AKCİĞER TÜBERKÜLOZLU OLGULARDAN İZOLE EDİLEN MYCOBACTERİUM TUBERCULOSİS İZOLATLARINDA PRİMER TÜBERKÜLOZ İLAÇ DİRENCİNİN ARAŞTIRILMASI
18
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China
19
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
20
Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses
21
Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China
22
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
23
Spoligotyping analysis of Mycobacterium tuberculosis in Khyber Pakhtunkhwa area, Pakistan
24
Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients
25
Application of a hybrid model in predicting the incidence of tuberculosis in a Chinese population
26
Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
27
Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China
28
Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
29
Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran
30
The blood transcriptional signature for active and latent tuberculosis
31
Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China
32
Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence
33
Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones
34
Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing
35
Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
36
Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils
37
Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China
38
Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria
39
Phenotypic and genotypic drug sensitivity of Mycobacterium tuberculosis complex isolated from South Omo Zone, Southern Ethiopia
40
Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal
41
Genetic polymorphisms of exon 1 of MBL2 contribute to tuberculosis risk especially in Asian populations: an updated meta-analysis of 26 studies
42
Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
43
Identifying differentially expressed long non-coding RNAs in PBMCs in response to the infection of multidrug-resistant tuberculosis
44
Mutation EthAW21R confers co-resistance to protionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
45
Association between tobacco smoking and drug-resistant tuberculosis
46
Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
47
Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones
48
Viability, biofilm formation, and MazEF expression in drug-sensitive and drug-resistant Mycobacterium tuberculosis strains circulating in Xinjiang, China
49
Clustering and recent transmission of Mycobacterium tuberculosis in a Chinese population
50
Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
51
The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis
52
Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis
53
Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia
54
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]
55
Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis
56
Association between the IL-6 gene polymorphism and tuberculosis risk: a meta-analysis
57
Diagnostic accuracy of Xpert MTB/RIF assay for musculoskeletal tuberculosis: a meta-analysis
58
Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia
59
Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
60
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
61
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study
62
Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia
63
Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
64
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
65
Delamanid expanded access novel treatment of drug resistant tuberculosis
66
Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis
67
Epidemiology and disease burden of tuberculosis in children: a global perspective
68
Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco
69
Current management options for latent tuberculosis: a review
70
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
71
Treatment of drug-resistant tuberculosis
72
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
73
Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence
74
AKCİĞER TÜBERKÜLOZLU OLGULARDAN İZOLE EDİLEN MYCOBACTERİUM TUBERCULOSİS İZOLATLARINDA PRİMER TÜBERKÜLOZ İLAÇ DİRENCİNİN ARAŞTIRILMASI
75
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China
76
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
77
Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses
78
Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China
79
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
80
AKCİĞER TÜBERKÜLOZLU OLGULARDAN İZOLE EDİLEN MYCOBACTERİUM TUBERCULOSİS İZOLATLARINDA PRİMER TÜBERKÜLOZ İLAÇ DİRENCİNİN ARAŞTIRILMASI
81
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China
82
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
83
Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses
84
Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China
85
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
86
Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report
87
Morbidity Trends and Risk of Tuberculosis: Mexico 2007–2017
88
Spoligotyping analysis of Mycobacterium tuberculosis in Khyber Pakhtunkhwa area, Pakistan
89
Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients
90
Application of a hybrid model in predicting the incidence of tuberculosis in a Chinese population
91
Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
92
Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China
93
Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
94
Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran
95
The blood transcriptional signature for active and latent tuberculosis
96
Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China
97
Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence
98
Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones
99
Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing
100
Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
101
Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils